Safety & Screening
Every patient completes a standardized intake and contraindication screening before any treatment is initiated. This protects your safety and ensures clinical appropriateness before your first treatment begins.
- Contraindication screening completed at intake — before treatment
- GLP-1 screening includes thyroid history, GI history, and more
- Hormone therapy screening includes PSA, hematocrit, sleep apnea, and cardiac history
- Signed informed consent required for all treatment pathways
- Adverse event protocol in place for between-visit concerns